Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
ACS Medicinal Chemistry Letters|February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse AgonistsYonghui Wang, Wei Cai, Ting Tang, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Bioorganic & Medicinal Chemistry|August 17, 2015
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonistsYonghui Wang, Ting Yang, Qian Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 29, 2023
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinomaQian Liang, Miaomiao Gong, Jing-Hua Zou, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt InhibitorsYonghui Wang, Wei Cai, Yaobang Cheng, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse AgonistsTing Yang, Qian Liu, Yaobang Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Pyridazine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yun Jin, et al.
Pageof 18